Try For Free 7-Day Free Trial
Lilly and Company discovers, develops, manufactures, and markets products in two business segments—human pharmaceutical products and animal health products. The mission of its human pharmaceutical business is to make medicines that help people live longer, healthier, more active lives. Most of the products Eli Lilly sells were discovered or developed by its own scientists, and the Company's success depends to a great extent on its ability to continue to discover, develop, and bring to market innovative new medicines. Eli Lilly's animal health business, operating through its Elanco division, develops, manufactures, and markets products for both food animals and companion animals. Eli Lilly manufactures and distributes its products through facilities in the US, Puerto Rico, and 11 other countries. Eli Lilly was originally incorporated in 1876 and is based in Indianapolis, Indiana.
|Overall||17 of 28|
|Sector (Life Science)||10 of 21|
|Type (Divestiture)||4 of 6|
|Country (Switzerland)||1 of 1|
|Year (2014)||1 of 1|
|Size (of disclosed)||3 of 18|
Siemens Medical Solutions - Two Investigational Positron
Siemens Medical Solutions - Two Investigational Positron Emission Tomography (PET) Tracers comprises two investigational positron emission tomography (PET) tracers, intended to image the neurofibrillary tangles in the brain for the diagnostics of Alzheimer's disease.
Eli Lilly - Sentinel and Spectrum Brands
Indianapolis, Indiana, United States
Virbac would acquire a combination of titles and rights for the United States on trademarks, marketing authorizations, patents, know-how, customer lists and other assets, related to two major parasiticides for dogs: Sentinel® Flavor Tabs and Sentinel® Spectrum, currently marketed in the United States by Novartis Animal Health.
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Company operates through three segments: Pharmaceuticals, Alcon, and Sandoz. Novartis was founded in 1996 and is based in Basel, Switzerland.
|Overall||3 of 6|
|Sector (Life Science)||3 of 4|
|Type (Divestiture)||2 of 5|
|Country (Switzerland)||2 of 4|
|Year (2014)||1 of 1|
|Size (of disclosed)||1 of 2|
Boston, California, United States
CoStim is is an emerging immuno-oncology company developing monoclonal antibody drugs that enable a patient's own immune system to better fight cancer.
Stamford, Connecticut, United States
Spinifex Pharmaceuticals, Inc. is a US-Australian biotechnology company developing new drug candidates for the treatment and management of chronic pain.